Mariner Lady Diamond– Time is eternal, diamonds shine forever.
Moonlight spills down onto the water in the harbor, its crystal clear, silvery light refracting and rippling across the liquid surface. On shore and onboard a yacht at the marina, three sophisticated women pause to glance at the time, their beautiful dress watches mirroring the cool, sparkling night light. The Concord Mariner Lady Diamond – the most elegant and desirable of dress watches. Like molten liquid, these glamorous timepieces curve sensuously around the wrist, shimmering gracefully, their diamonds shining eternally.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7449251-baselworld-2015-concord-presents-new/
See the whole review here http://www.osv.ltd.uk/citroen.phpThe
Citroen C1 will appeal to motorists looking for car lease deals on a
reliable, fun way to get about town. It helps that this smart little
city car is cheap to run -- which makes it a great choice as a first
car for a young driver. The Citroen C1 will also appeal as a second car
option for family drivers looking for car leasing deals.
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
